Biomaterials for intranasal and inhaled vaccine delivery
- PMID: 36987501
- PMCID: PMC10041562
- DOI: 10.1038/s44222-022-00012-6
Biomaterials for intranasal and inhaled vaccine delivery
Abstract
Delivery of vaccines by nasal sprays may enable more robust, protective mucosal immune responses against infectious diseases, such as COVID-19, compared with intramuscular injection. In this Comment, we highlight how biomaterials can be designed to allow intranasal and inhaled vaccination.
Figures
References
-
- Topol EJ & Iwasaki A Operation nasal vaccine — lightning speed to counter COVID-19. Sci. Immunol 74, Eadd9947 (2022). - PubMed
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources